Skip to Content

Camzyos

Licence status
Authorised: 26/06/2023
Active substances
Mavacamten
Dosage Form
Capsule, hard
Licence number
EU/1/23/1716/001-002/009
Licence holder
Bristol-Myers Squibb Pharma EEIG

Licence information

ATC code
C01EB Other cardiac preparations, C01EB24 mavacamten
Route of supply
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
26/06/2023

Stay updated: document advice

The information and documents on this page are subject to frequent updates. We recommend you do not retain saved or printed versions of them. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie